Why this Peninsula startup is primed for an $80.5M IPO

John Fowler and Chris Kirk three years ago were talking about starting a company focused on developing drugs to right a hyperactive immune system. On Thursday their company filed paperwork for an IPO that could raise $80.5 million. Kezar Life Sciences Inc., which would trade on the NASDAQ exchange as "KZR," is the fifth Bay Area life sciences company this year to file for an IPO, and it's indicative of the ability founders have to go public early in the process of building a drug development company. Spun…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news